Vascular Genetics

Presentations, Testing, and Prognostics

Aaron W. Aday, Sarah E. Kreykes, Christina Fanola

Research output: Contribution to journalReview article

Abstract

Purpose of review: Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular diseases. The goal of this review is to provide clinicians a reference to help identify and diagnose different types of vascular disease with a genetic underpinning. Recent findings: Ongoing studies have identified numerous genes involved in the TGF-β signaling pathway that are also associated with thoracic aortic aneurysm and dissection, and it is possible to test for pathogenic variants in these genes in the clinical setting using commercially available genetic testing panels. Additional studies have begun to identify genetic variants associated with an increased risk of bicuspid aortic valve, abdominal aortic aneurysm, and fibromuscular dysplasia. Summary: With increased availability of low-cost genetic testing, clinicians are now able to not only definitively diagnose some vascular syndromes but also provide information on the risk of disease in other family members, as well as provide guidance in terms of family planning. As the cost of genetic testing continues to drop with the benefit of increasing insurance coverage, genetic data will increasingly become part of clinical care for many patients with vascular disease.

Original languageEnglish (US)
Article number103
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume20
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Genetic Testing
Vascular Diseases
Blood Vessels
Fibromuscular Dysplasia
Thoracic Aortic Aneurysm
Costs and Cost Analysis
Aortic Diseases
Insurance Coverage
Abdominal Aortic Aneurysm
Family Planning Services
Genes
Dissection
Patient Care

Keywords

  • Aneurysm
  • Aortic disease
  • Dissection
  • Vascular genetics

PubMed: MeSH publication types

  • Journal Article
  • Review

Cite this

Vascular Genetics : Presentations, Testing, and Prognostics. / Aday, Aaron W.; Kreykes, Sarah E.; Fanola, Christina.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 20, No. 12, 103, 01.12.2018.

Research output: Contribution to journalReview article

@article{c96dd7abc9d64bc68b1d46040f419330,
title = "Vascular Genetics: Presentations, Testing, and Prognostics",
abstract = "Purpose of review: Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular diseases. The goal of this review is to provide clinicians a reference to help identify and diagnose different types of vascular disease with a genetic underpinning. Recent findings: Ongoing studies have identified numerous genes involved in the TGF-β signaling pathway that are also associated with thoracic aortic aneurysm and dissection, and it is possible to test for pathogenic variants in these genes in the clinical setting using commercially available genetic testing panels. Additional studies have begun to identify genetic variants associated with an increased risk of bicuspid aortic valve, abdominal aortic aneurysm, and fibromuscular dysplasia. Summary: With increased availability of low-cost genetic testing, clinicians are now able to not only definitively diagnose some vascular syndromes but also provide information on the risk of disease in other family members, as well as provide guidance in terms of family planning. As the cost of genetic testing continues to drop with the benefit of increasing insurance coverage, genetic data will increasingly become part of clinical care for many patients with vascular disease.",
keywords = "Aneurysm, Aortic disease, Dissection, Vascular genetics",
author = "Aday, {Aaron W.} and Kreykes, {Sarah E.} and Christina Fanola",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s11936-018-0703-2",
language = "English (US)",
volume = "20",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "12",

}

TY - JOUR

T1 - Vascular Genetics

T2 - Presentations, Testing, and Prognostics

AU - Aday, Aaron W.

AU - Kreykes, Sarah E.

AU - Fanola, Christina

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Purpose of review: Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular diseases. The goal of this review is to provide clinicians a reference to help identify and diagnose different types of vascular disease with a genetic underpinning. Recent findings: Ongoing studies have identified numerous genes involved in the TGF-β signaling pathway that are also associated with thoracic aortic aneurysm and dissection, and it is possible to test for pathogenic variants in these genes in the clinical setting using commercially available genetic testing panels. Additional studies have begun to identify genetic variants associated with an increased risk of bicuspid aortic valve, abdominal aortic aneurysm, and fibromuscular dysplasia. Summary: With increased availability of low-cost genetic testing, clinicians are now able to not only definitively diagnose some vascular syndromes but also provide information on the risk of disease in other family members, as well as provide guidance in terms of family planning. As the cost of genetic testing continues to drop with the benefit of increasing insurance coverage, genetic data will increasingly become part of clinical care for many patients with vascular disease.

AB - Purpose of review: Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular diseases. The goal of this review is to provide clinicians a reference to help identify and diagnose different types of vascular disease with a genetic underpinning. Recent findings: Ongoing studies have identified numerous genes involved in the TGF-β signaling pathway that are also associated with thoracic aortic aneurysm and dissection, and it is possible to test for pathogenic variants in these genes in the clinical setting using commercially available genetic testing panels. Additional studies have begun to identify genetic variants associated with an increased risk of bicuspid aortic valve, abdominal aortic aneurysm, and fibromuscular dysplasia. Summary: With increased availability of low-cost genetic testing, clinicians are now able to not only definitively diagnose some vascular syndromes but also provide information on the risk of disease in other family members, as well as provide guidance in terms of family planning. As the cost of genetic testing continues to drop with the benefit of increasing insurance coverage, genetic data will increasingly become part of clinical care for many patients with vascular disease.

KW - Aneurysm

KW - Aortic disease

KW - Dissection

KW - Vascular genetics

UR - http://www.scopus.com/inward/record.url?scp=85056566601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056566601&partnerID=8YFLogxK

U2 - 10.1007/s11936-018-0703-2

DO - 10.1007/s11936-018-0703-2

M3 - Review article

VL - 20

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 12

M1 - 103

ER -